AI is assisting researchers in helping to treat deadly diseases, customize medications and find hard-to-spot cells in the human body.
Artificial intelligence is rapidly transforming medicine, enabling unprecedented advancements from personalized cancer treatments to early disease detection. A prime example is the recent 'landmark moment' in developing a melanoma vaccine by Moderna and Merck, which utilizes AI to analyze tumor samples and create highly customized therapies for 1,100 patients. This signifies a shift towards more precise and effective medical interventions, potentially ushering in a 'golden age' of medicine.
A significant advantage of AI in medicine is its ability to swiftly analyze vast amounts of medical data, including decades of research, case studies, and testing results, far exceeding human capacity. Dr. David Fajgenbaum's 'Every Cure' non-profit leverages this by employing AI as a 'matchmaker' to score millions of potential combinations between 4,000 existing FDA-approved drugs and 18,000 diseases, identifying unexpected and life-saving applications, even for conditions like depression and breast cancer.
Kaila Mabus's battle with Castleman disease, a rare lymphatic disorder, highlights AI's life-changing impact. After numerous failed treatments and grim prognoses, Dr. Fajgenbaum's AI-driven approach identified Ruxolitinib, a blood cancer drug, as an effective, albeit off-label, treatment. This personalized intervention 'woke up' her kidneys and gave her 'a new life,' demonstrating the potential to repurpose existing drugs for rare or previously untreatable conditions, saving her from needing a kidney transplant.
AI is also making strides in reproductive medicine. Columbia University's Sperm Tracking And Recovery (STAR) system uses artificial intelligence coupled with powerful microscopes to overcome the immense challenge of finding a single viable sperm cell amidst billions of cell fragments and debris in men previously deemed infertile due to a lack of visible sperm. This AI-driven precision has enabled successful pregnancies where traditional methods failed, turning a 'mind-numbing' human task into an efficient, life-creating process.
Beyond treatment discovery, AI is enhancing diagnostic capabilities and personalized cancer care. Researchers at the University of Hong Kong developed CardiOmicScore, an AI-powered blood test that can predict heart disease up to 15 years in advance. Concurrently, UCLA scientists, led by Dr. Michael Teitell, combine AI with 3D bioprinting and advanced imaging to grow tumor replicas and determine customized, highly effective drug protocols for individual cancer patients, moving beyond one-size-fits-all chemotherapy approaches to target unique disease biologies.
The outlook for AI in healthcare is incredibly promising. Dr. Fajgenbaum anticipates rapid progress in the coming years, citing potential applications such as the use of AI combined with audio processing for early diagnosis and monitoring of ALS (Amyotrophic Lateral Sclerosis) progression. These ongoing developments underscore AI's profound potential to revolutionize various aspects of medicine, leading to better diagnostic tools, more effective treatments, and ultimately, saving billions of lives globally.